-
Why Is Radiopharm Theranostics Stock Rallying Over 140%?
15 Dec 2025 17:07 GMT
… of suspected recurrent brain metastases from solid tumors … PET imaging of brain metastases.
The results showed … the brain metastases. Images confirm metabolic activity in brain metastases compared … treatment effect in brain metastases originating from solid …
-
Biotechs get their clinical trial ducks in a row
15 Dec 2025 02:08 GMT
… imaging trial for brain metastases.
The company says … in suspected or recurrent brain metastases”.
Dubbed RAD-101 … patients have confirmed recurrent brain metastases, from solid tumours … are diagnosed with brain metastases annually. Independent research …
-
<![CDATA[SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer]]>
13 Dec 2025 22:52 GMT
… analyses in patients with baseline brain metastases suggested a doubling of PFS … historically limited therapeutic options for brain metastases, which occur in up to … encouraging PFS in patients with brain metastases.
5. Safety and Dosing Considerations …
-
<![CDATA[Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer]]>
13 Dec 2025 01:28 GMT
… the highest incidence of brain metastases (BMs), affecting 30% … of ADCs in treating brain metastases, emphasizing their central … both stable and active brain metastases who received the … patients with breast cancer brain metastases and recurrent glioblastoma: …
-
<![CDATA[The Battle Between MARIPOSA and FLAURA2 Regimens in NSCLC]]>
12 Dec 2025 17:57 GMT
… 40% had a history of brain metastases, and 97% vs 97% had … 40% had a history of brain metastases, and 99% vs 99% had …
-
<![CDATA[Monitoring and Optimizing Treatment Response in LEMS Management]]>
12 Dec 2025 16:02 GMT
… ;day, especially in individuals with brain metastases or prior seizure history, and …
-
Focused Ultrasound in Brain Tumors: Mechanisms, Imaging Guidance, and Emerging Clinical Applications
12 Dec 2025 14:32 GMT
… brain tumors, including glioblastoma (GBM), brain metastases, and diffuse intrinsic pontine glioma …
-
Pfizer Reports Strong Phase 3 Results for TUKYSA in HER2+ Breast Cancer
12 Dec 2025 12:51 GMT
… or without a history of brain metastases at baseline.
Although the secondary …
-
<![CDATA[ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy]]>
12 Dec 2025 06:07 GMT
… better penetration and activity in brain metastases, demonstrated in preclinical and early …
-
<![CDATA[HER2CLIMB-05: Tucatinib Added to Maintenance HP Extends PFS in HER2+ Metastatic Breast Cancer]]>
12 Dec 2025 00:46 GMT
… patients with or without baseline brain metastases during maintenance therapy?
Erika Hamilton … option for patients that have brain metastases.